期刊文献+

干细胞样SP细胞研究进展 被引量:3

Advances in the stem cell-like side population cells
下载PDF
导出
摘要 干细胞样SP细胞是近年来在很多正常组织和恶性肿瘤组织及细胞系中发现的一种具有不同程度分化潜能和自我更新能力的细胞群体。虽然SP细胞在总体细胞中所占比例很低,但这部分具有干细胞特性的细胞在干细胞以及肿瘤干细胞研究方面起着越来越重要的作用。本文综述了SP细胞的发现、生物学特性、与肿瘤干细胞之间的关系以及SP细胞的未来临床应用等。最后对SP细胞的发展进行了展望。 Recently, stem cell like side population(SP) cells have been found in many normal organizations and malig-nant tumors, which have the proficiency of differentiation and self-renewal. These cells play an important role in cancer stemcell research, though they occupy a low proportion in total cells. Here, we reviewed the foundation of SP cells, and their rela-tionship with stem cells, and the clinical application in the future.
作者 胡均 岳欣
出处 《天津医药》 CAS 2016年第4期505-508,共4页 Tianjin Medical Journal
基金 国家自然科学基金资助项目(81101870) 天津市卫生局科技基金项目(2014KZ080)
关键词 干细胞 肿瘤干细胞 综述 SP细胞 stem cells neoplastic stem cells review SP cells
  • 相关文献

参考文献47

  • 1郑丹薇,廖珊,朱广超,周艳宏,李桂源.侧群细胞及其在肿瘤干细胞研究中的进展[J].中南大学学报(医学版),2014,39(5):525-531. 被引量:8
  • 2Li DQ, Wang Z, Yoon KC, et al. Characterization, isolation, expan-sion and clinical therapy of human corneal epithelial stem/progeni-tor cells[J].J Stem Cells,2014,9(2) : 79-91.
  • 3Masuda H, Maruyama T,Cargett CE,et al. Endometrial side populationcells : potential adult stem/progenitor cells in endometrium[J].BiolReprod,2015,93(4): 84. doi: 10.1095/biolreprod. 115.131490.
  • 4Inagaki T, Kusunoki S,Tabu K, et a].Up-regulation of lymphocyteantigen 6 complex expression in side-population cells derived froma human trophoblast cell line HTR-8/SVneo[J].Hum Cell,2016,29(1): 10-21. doi: 10.1007/sl3577-015-0121-7.
  • 5胡均,秦仁义,黄丹,陈敏,王敏,杜志勇,刘文松.人胆囊癌SP细胞的分离及ABCG2和Oct-4的表达[J].中华肝胆外科杂志,2008,14(9):640-643. 被引量:4
  • 6胡均,柳建中,岳欣,李健,秦仁义.人胆囊癌SP细胞的分离及其干细胞标记物的表达[J].中国肿瘤临床,2010,37(1):44-47. 被引量:3
  • 7Kong X,Ma MZ,Zhang Y,et al. Differentiation therapy : sesamin asan effective agent in targeting cancer stem- like side populationcells of human gallbladder carcinoma[J].BMC Complement AltemMed,2014,14: 254. doi: 10,1186/1472-6882-14-254.
  • 8She JJ, Zhang PG, Wang X, et al. Side population cells isolatedfrom KATO III human gastric cancer cell line have cancer stemcell- like characteristics[J].World J Gastroenterology, 2012, 18(33): 4610-4617. doi: 10.3748/wjg.vl8.i33.4610.
  • 9Gao G,Sun Z,Wenyong L,et al. A preliminary study of side popula-tion cells in human gastric cancer cell tine HGC-27[J].Ann Trans-plant,2015 ,20: 147-153. doi: 10.12659/AOT.892197.
  • 10Van den Broeck A, Vankelecom H, Van Delm W,et al. Human pan-creatic cancer contains a side population expressing cancer stemcell-associated and prognostic genes[J].PLoS One, 2013,8 (9):e73968. doi : 10.1371/journal.pone.0073968.

二级参考文献50

  • 1Zhou S, Schuetz JD, Bunting KD,et al. The ABC transporter Bcrpl/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med,2001, 7:1028-1034.
  • 2Lechner A, Leech CA, Abraham EJ,et al. Nestin-positive progenitor cells derived from adult human pancreatic islets of Langerhans contain side population (SP) cells defined by expression of the ABCG2 (BCRP1) ATP binding cassette transporter. Biochem Biophys Res Commun, 2002,293 : 670-674.
  • 3Hill RP. Identifying cancer stem cells in solid tumors: case not proven. Cancer Res, 2006, 66:1891-1896.
  • 4Wulf GG, Luo KL, Jackson KA, et al. Cells of the hepatic side population contribute to liver regeneration and can be replenished with bone marrow stem cells. Haematologica, 2003, 88: 368-378.
  • 5Olmsted-Davis EA, Gugala Z, Camargo F,et al. Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc NatlAcad Sci U SA, 2003, 100: 15877-15882.
  • 6Doyle LA, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP(ABCG2). Oncogene, 2003,22 : 7340- 7358.
  • 7Sarkadi B, Homolya L, Szakacs G, et al. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol Rev, 2006, 86: 1179- 1236.
  • 8Perez Tomas R. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Curr Med Chem, 2006, 13: 1859-1876.
  • 9Gidekel S, Pizov G, Bergman Y,et al. Oct-3/4 is a dose-dependent oncogenie fate determinant. Cancer Cell, 2003, 4:361-370.
  • 10Jones TD, Ulhright TM, Eble JN, et al. OCT-4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol, 2004, 28: 935- 940.

共引文献16

同被引文献59

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部